Fondazione Poliambulanza Istituto Ospedaliero
Brescia 25124
3 studies enrolling now · 15 studies all time
What they study most
Aortic Stenosis, Aortic Valve Disease, Atrial Fibrillation, CRC (Colorectal Cancer), Cardiac Valve Disease, Chemotherapy-Induced Nausea and Vomiting, Endoscopic Mucosal Resection, First Line Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Neoplasms, Polyp of Colon, Recurrent Colon Adenoma
Studies at this site
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
- The Fourth Left Atrial Appendage Occlusion Study — Recruiting now
- CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting — Recruiting now
- A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
- ABTECT - Maintenance — Running, not enrolling
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
- Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis — Completed
- ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
- Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
- Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
- Sorin Universal REgistry on Aortic Valve Replacement — Stopped early
- EndoRotor® Endoscopic Mucosal Resection System for the Colon — Completed
- An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting — Completed
- A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer — Stopped early
- An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting — Completed